Fascination About GW7647
Other clinical trials in individuals with non-Hodgkin's lymphoma [24] and individuals with Innovative malignancy [14] have revealed also that zosuquidar didn't appreciably affect the pharmacokinetics of doxorubicin and experienced average outcomes to the pharmacokinetics of vincristine. These medical trials accepted that zosuquidar could securely a